PNU-100480

DRUG3 trials

Sponsors

Sequella, Inc.

Conditions

Tuberculosis

Phase 1

Safety, Tolerability And Pharmacokinetics Study Of Single Doses Of PNU-100480 In Healthy Adults

CompletedNCT00871949

Sequella, Inc.Tuberculosis

Start: 2009-04-30End: 2009-08-31Updated: 2013-08-27

Safety, Tolerability, Pharmacokinetics And Measurement Of Whole Blood Activity (WBA) Of PNU-100480 After Multiple Oral Doses In Healthy Adult Volunteers

CompletedNCT00990990

Sequella, Inc.Tuberculosis

Start: 2009-10-31End: 2010-05-31Updated: 2013-08-28

Phase 2

PNU-100480 In Newly Diagnosed, Drug Sensitive Patients With Pulmonary TB; Early Bactericidal Activity; Whole Blood Assay

CompletedNCT01225640

Sequella, Inc.Tuberculosis

Start: 2011-08-31End: 2011-12-31Updated: 2016-01-14

Related Papers

Mycobactericidal Activity of Sutezolid (PNU-100480) in Sputum (EBA) and Blood (WBA) of Patients with Pulmonary Tuberculosis

PLoS ONE2014-04-14161 citations